1 C A S E S T U D Y Oncology C A S E S T U D Y Oncology Toll- Free (USA): 888-987-2691 mcsmo@makrocare.com www.makrocare.com/MCSMO USA I UK I EUROPE I ASIA Indication: NSCLC (Non Small Cell Lung Cancer) Study Design: A phase III double blind, randomized study in patients with NSCLC Opportunity: MCSMO was selected for patient recruitment services with enrollment duration of 18 months with 87

Join for free to read